PureTech Health plc (OTCMKTS:PTCHF – Get Free Report)’s stock price fell 2% during mid-day trading on Tuesday. The company traded as low as $1.4450 and last traded at $1.51. 11,775 shares were traded during trading, a decline of 65% from the average session volume of 34,122 shares. The stock had previously closed at $1.5410.
PureTech Health Trading Down 2.0%
The business’s 50-day moving average price is $1.57 and its 200 day moving average price is $1.64.
About PureTech Health
PureTech Health plc is a biopharmaceutical company that develops medicines for complex diseases, with a focus on therapeutic approaches designed to address significant unmet patient needs. The company combines its own research and development activities with a model of creating, financing and advancing subsidiary companies that pursue distinct therapeutic programs.
PureTech’s research platform includes orally administered medicines and other treatments intended to influence biological pathways that are difficult to target with conventional drug-delivery methods.
Recommended Stories
- Five stocks we like better than PureTech Health
- Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AI
- Lamb Weston’s Turnaround Is Starting to Look Real
- These 3 Stocks Got the Most Love From Analysts in September
- Record French Debt Could Create Opportunities for U.S. Market Operators
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
